CANCER ADVANCES
Cancer Advances is a biotechnology company focused on impacting human health and the progression of gastrointestinal cancers by enhancing the adaptive immune system. The company is led by an experienced management team and has a broad intellectual property portfolio. Cancer Advances is a wholly owned subsidiary of Cato BioVentures. The company's lead compound, Polyclonal Antibody Stimulator (PAS), is an immunomodulator used to treat gastrointestinal cancer. Please visit their Product page for more information on what is in development.
CANCER ADVANCES
Industry:
Biotechnology
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.canceradvancesinc.com
Status:
Closed
Contact:
919-361-2286
Email Addresses:
[email protected]
Technology used in webpage:
Microsoft Exchange Online Google Maps Amazon Route 53 Network Solutions
Current Employees Featured
Official Site Inspections
http://www.canceradvancesinc.com
Unable to get host informations!!!
